Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients (NIS-PUB)

AstraZeneca

Status: Completed

Conditions: Re-bleeding in NVUGIB

Study type: Observational

Funder types: Industry

Identifiers

NCT01292915

NIS-GVN-DUM-2010/1

Details and patient eligibility

About

The main aim of the study is to describes the outcomes of patients with Upper Gastrointestinal Bleed (UGIB) in a real-life setting. Additionally analyse assessed predictors of outcome, including the impact of hemostatic endoscopic and pharmacologic therapies.

Full description

MSD

Enrollment: 1,044 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients (>=18yrs) admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia...
• Evidence that an upper GI endoscopy was performed

Exclusion criteria

• GI bleeding not from NVUGIB

Trial design

1,044 participants in 1 patient group

1